未登录

J

Jun-Bom Park

Sahmyook University

H指数:25

被引数:1,725

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development and bioavailability modulation of once-daily controlled release apixaban tablets by utilizing functional pharmaceutical excipients

通过利用功能性药用辅料开发一日一次的控释阿哌沙班片剂及其生物利用度调控

Journal of Drug Delivery Science and Technology

IF4.9

2026-02-120

PRE

Comparative stabilization mechanism of self-assembling fattigated gelatin, micellar polyethylene glycol hexadecyl ether, and electrostatic interactive xanthan gum for aqueous labile decitabine

自组装疲劳明胶、胶束化聚乙二醇十六烷基醚以及静电互作黄原胶对水不稳定地塞米松的对比稳定化机制

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2025-04-010

PRE

Release-modulating mechanism and comparative pharmacokinetics in beagle dogs of bethanechol-loaded oral dosage forms

beagle犬口服剂型的释放调节机制和比较药代动力学

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2025-01-010

PRE

Development of 3D-printed dual-release fixed-dose combination through double-melt extrusion

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2024-08-012

PRE

Advancements of hot-melt extrusion technology to address unmet patient needs and pharmaceutical quality aspects

JOURNAL OF PHARMACEUTICAL INVESTIGATION

IF5.1

2024-06-222

PRE

Nanonization and Deformable Behavior of Fattigated Peptide Drug in Mucoadhesive Buccal Films

IF5.5

2024-03-273

OAAI

Development of a self-microemulsifying drug delivery system using a Dunnione to enhance bioavailability

JOURNAL OF PHARMACEUTICAL INVESTIGATION

IF5.1

2024-03-124

PRE

Polyelectrolyte-based solid dispersions for enhanced dissolution and pH-Independent controlled release of sildenafil citrate

IF3.6

2023-12-011

OAAI

Cellular Efficacy of Fattigated Nanoparticles and Real-Time ROS Occurrence Using Microfluidic Hepatocarcinoma Chip System: Effect of Anticancer Drug Solubility and Shear Stress

PHARMACEUTICALS

IF4.8

2023-09-202

OAAI

Investigation of Patient-Centric 3D-Printed Orodispersible Films Containing Amorphous Aripiprazole

PHARMACEUTICALS

IF4.8

2022-07-1920

OAAI

Improved Bioavailability of Poorly Water-Soluble Drug by Targeting Increased Absorption through Solubility Enhancement and Precipitation Inhibition

PHARMACEUTICALS

IF4.8

2021-12-023

OAAI

Modulation of the clinically accessible gelation time using glucono-d-lactone and pyridoxal 5′-phosphate for long-acting alginate in situ forming gel injectable

CARBOHYDRATE POLYMERS

IF12.5

2021-11-0112

PREAI

Effect of pH adjustment and ratio of oppositely charged polymers on the mechanistic performance and sustained release of volatile perfume in interpolyelectrolyte complex microcapsules

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2021-07-013

PREAI

Development of Pelubiprofen Tromethamine with Improved Gastrointestinal Safety and Absorption

IF5.5

2021-05-184

OAAI

Development and Validation of an LC-MS/MS Assay to Quantitate 2′,4′,6′-Trihydroxyacetophenone in Rat and Dog Plasma and its Application to a Pharmacokinetic Study

IF4.6

2020-09-230

OAAI

Preparation of Hot-Melt Extruded Dosage Form for Enhancing Drugs Absorption Based on Computational Simulation

IF5.5

2020-08-111

OAAI

Preparation and evaluation of identifiable quick response (QR)-coded orodispersible films using 3D printer with directly feeding nozzle

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2020-06-0129

PREAI

Utilization of a fattigation platform gelatin-oleic acid sodium salt conjugate as a novel solubilizing adjuvant for poorly water-soluble drugs via self-assembly and nanonization

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2020-02-0117

PREAI

Fabrication of Intragastric Floating, Controlled Release 3D Printed Theophylline Tablets Using Hot-Melt Extrusion and Fused Deposition Modeling

IF5.5

2020-01-1775

OAAI

Customized Novel Design of 3D Printed Pregabalin Tablets for Intra-Gastric Floating and Controlled Release Using Fused Deposition Modeling

IF5.5

2019-10-3062

OAAI